C. Karimkhani, V. Wanga, L. E. Coffeng, P. Naghavi, R. P. Dellavalle et al.,

, Global burden of cutaneous leishmaniasis: a cross-sectional analysis from the Global Burden of Disease Study, Lancet Infect Dis, vol.16, pp.584-91, 2013.

E. Schwartz, C. Hatz, and J. Blum, New world cutaneous leishmaniasis in travellers, Lancet Infect Dis, vol.6, pp.342-351, 2006.

J. Dedet, B. Carme, N. Desbois, G. Bourdoiseau, L. Lachaud et al.,

, Épidémiologie des leishmanioses autochtones en France métropolitaine et d'outremer, Presse Med, vol.42, pp.1469-81, 2013.

S. Simon, M. Nacher, B. Carme, C. Basurko, A. Roger et al., Cutaneous leishmaniasis in French Guiana: revising epidemiology with PCR-RFLP, Trop Med Health, vol.45, p.5, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01898045

P. A. Buffet, É. Rosenthal, J. Gangneux, E. Lightburne, P. Couppié et al.,

, Traitement des leishmanioses en France : proposition d'un référentiel consensuel

, Presse Med, vol.40, pp.173-84, 2011.

B. Rotureau, M. Joubert, E. Clyti, F. Djossou, and B. Carme, Leishmaniasis among gold miners, French Guiana, Emerg Infect Dis, vol.12, pp.1169-70, 2006.

F. Berger, P. Romary, D. Brachet, C. Rapp, P. Imbert et al., Épidémie de leishmaniose cutanée chez des militaires de retour de mission en Guyane, Rev Epidemiol Sante Publique, vol.54, pp.213-234, 2006.

S. Banzet, Leishmaniose cutanée chez les militaires en opération en Guyane française, Med Trop, vol.60, pp.297-302, 2000.

E. Lightburn, J. B. Meynard, J. J. Morand, E. Garnotel, P. Kraemer et al.,

, Synthèse de données militaires sur 10 ans, Med Trop, vol.62, pp.545-53, 2002.

M. Nacher, B. Carme, S. Marie, D. Couppié, P. Clyti et al., Seasonal fluctuations of incubation, healing delays, and clinical presentation of cutaneous leishmaniasis in French Guiana, J Parasitol, vol.87, pp.1495-1503, 2001.

S. Simon, V. Veron, and B. Carme, Leishmania spp. identification by polymerase chain reaction-restriction fragment length polymorphism analysis and its applications in French Guiana, Diagn Microbiol Infect Dis, vol.66, issue.2, pp.175-80, 2010.

M. Nacher, B. Carme, S. Marie, D. Couppié, P. Clyti et al., Influence of clinical presentation on the efficacy of a short course of pentamidine in 16 the treatment of cutaneous leishmaniasis in French Guiana, Ann Trop Med Parasitol, vol.95, pp.331-337, 2001.

L. O. Neves, A. C. Talhari, E. P. Gadelha, S. Júnior, R. M. Guerra et al., A randomized clinical trial comparing meglumine antimoniate, pentamidine and amphotericin B for the treatment of cutaneous leishmaniasis by Leishmania guyanensis, An Bras Dermatol, vol.86, pp.1092-101, 2011.

E. Bourreau, M. Ginouves, G. Prévot, M. A. Hartley, J. P. Gangneux et al.,

F. Gangneux, Presence of Leishmania RNA Virus 1 in Leishmania guyanensis increases the risk of first-line treatment failure and symptomatic relapse, J Infect Dis, vol.213, pp.105-116, 2016.

N. Aronson, B. L. Herwaldt, M. Libman, R. Pearson, R. Lopez-velez et al., Diagnosis and treatment of leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the, Clin Infect Dis, vol.63, pp.1539-57, 2016.

G. A. Romero, M. V. Guerra, M. G. Paes, and M. Vo, Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: therapeutic response to meglumine antimoniate, Am J Trop Med Hyg, vol.65, pp.456-65, 2001.

M. Nacher, P. Couppié, B. Carme, E. Clyti, S. Marie et al., Influence of meteorological parameters on the clinical presentation of cutaneous leishmaniasis in French Guiana and on the efficacy of pentamidine treatment of the disease, Ann Trop Med Parasitol, vol.96, pp.773-80, 2002.

V. Adaui, L. Lye, N. S. Akopyants, M. Zimic, A. Llanos-cuentas et al., Association of the endobiont double-stranded RNA Virus LRV1 with treatment failure for human leishmaniasis caused by Leishmania braziliensis in Peru and Bolivia, J Infect Dis, vol.213, pp.112-133, 2016.

P. Machado, C. Araújo, D. Silva, A. T. Almeida, R. P. et al., Failure of early treatment of cutaneous leishmaniasis in preventing the development of an ulcer, Clin Infect Dis, vol.34, pp.69-73, 2002.

E. Bourreau, C. Ronet, E. Darsissac, M. Lise, D. S. Marie et al., In leishmaniasis due to Leishmania guyanensis infection, distinct intralesional interleukin-10 and Foxp3 mRNA expression are associated with unresponsiveness to treatment, J Infect Dis, vol.199, pp.576-585, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00911620

P. Couppié, E. Clyti, M. Sobesky, F. Bissuel, D. Giudice et al., Comparative study of cutaneous leishmaniasis in human immunodeficiency virus (HIV)-infected patients and non-HIV-infected patients in French Guiana, Br J Dermatol, vol.151, pp.1165-71, 2004.

A. Llanos-cuentas, G. Tulliano, R. Araujo-castillo, C. Miranda-verastegui, G. Santamaria-castrellon et al., Clinical and parasite species risk factors for pentavalent antimonial treatment failure in cutaneous leishmaniasis in Peru, Clin Infect Dis, vol.46, pp.223-254, 2008.

P. I. Tarr, R. F. Aline, B. L. Smiley, J. Scholler, J. Keithly et al., LR1: a candidate RNA virus of, Leishmania Proc Natl Acad Sci, vol.85, pp.9572-9577, 1988.

A. Ives, C. Ronet, F. Prevel, G. Ruzzante, S. Fuertes-marraco et al.,

, Leishmania RNA virus controls the severity of mucocutaneous leishmaniasis, Science, vol.331, pp.775-783, 2011.

M. Hartley, C. Ronet, H. Zangger, S. M. Beverley, and N. Fasel, Leishmania RNA virus: when the host pays the toll, Front Cell Infect Microbiol, vol.2, p.99, 2012.

G. Van-der-auwera, A. Bart, C. Chicharro, S. Cortes, L. Davidsson et al., Comparison of Leishmania typing results obtained from 16 European clinical laboratories in 2014, Euro Surveill, vol.21, 2016.

P. Delobel and R. Pradinaud, Rhabdomyolysis associated with pentamidine isethionate therapy for American cutaneous leishmaniasis, J Antimicrob Chemother, vol.51, pp.1319-1339, 2003.

A. Lieber-mbomeyo, D. Lipsker, M. Miléa, and E. Heid, Rhabdomyolyse induite par l'iséthionate de pentamidine (Pentacarinat®) lors du traitement d'une leishmaniose cutanée : 2 cas, Ann Dermatol Venereol, vol.129, pp.50-52, 2002.

E. R. Levy, L. Musick, M. S. Zinter, T. Lang, M. J. Cowan et al., Safe and Effective Prophylaxis with Bimonthly Intravenous Pentamidine in the Pediatric Hematopoietic Stem Cell Transplant Population, Pediatr Infect Dis J, vol.35, pp.135-176, 2016.

J. M. Demasi, J. A. Cox, D. Leonard, A. Y. Koh, and V. M. Aquino, Intravenous pentamidine is safe and effective as primary pneumocystis pneumonia prophylaxis in children and adolescents undergoing hematopoietic stem cell transplantation, Pediatr Infect Dis J, vol.32, pp.933-939, 2013.

M. Roussel, M. Nacher, G. Frémont, B. Rotureau, E. Clyti et al., Comparison between one and two injections of pentamidine isethionate, at 7 mg/kg in each injection, in the treatment of cutaneous leishmaniasis in French Guiana, Ann Trop Med Parasitol, vol.100, pp.307-321, 2006.

E. Lightburn, J. J. Morand, J. B. Meynard, P. Kraemer, B. Chaudier et al.,

, Thérapeutique des leishmanioses tégumentaires du Nouveau Monde. Expérience à propos de 326 cas traités par iséthionate de pentamidine à fortes doses, Med Trop, vol.63, pp.35-44, 2003.

W. F. Van-der-meide, L. O. Sabajo, A. J. Jensema, I. Peekel, W. R. Faber et al., Evaluation of treatment with pentamidine for cutaneous leishmaniasis in Suriname, Int J Dermatol, vol.48, pp.52-60, 2009.

J. P. Gangneux, S. Sauzet, S. Donnard, N. Meyer, A. Cornillet et al.,

, Recurrent American cutaneous leishmaniasis. Emerg Infect Dis, vol.13, pp.1436-1444, 2007.

P. Desjeux and J. P. Dedet, Isoenzyme characterization of 112 Leishmania isolates from French Guiana, Trans R Soc Trop Med Hyg, vol.83, pp.610-612, 1989.

M. Ginouvès, S. Simon, E. Bourreau, V. Lacoste, C. Ronet et al.,

, Prevalence and Distribution of Leishmania RNA Virus 1 in Leishmania parasites from French Guiana, Am J Trop Med Hyg, vol.94, pp.102-108, 2016.